Smith Group Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,970
| Closed | -$124K | – | 340 |
|
|
2020
Q2 | $124K | Sell |
1,970
-30
| -2% | -$1.89K | 0.01% | 185 |
|
|
2020
Q1 | $102K | Hold |
2,000
| – | – | 0.01% | 213 |
|
|
2019
Q4 | $159K | Hold |
2,000
| – | – | 0.01% | 215 |
|
|
2019
Q3 | $97K | Buy |
2,000
+320
| +19% | +$15.5K | ﹤0.01% | 239 |
|
|
2019
Q2 | $88K | Hold |
1,680
| – | – | ﹤0.01% | 247 |
|
|
2019
Q1 | $89K | Sell |
1,680
-3,180
| -65% | -$168K | ﹤0.01% | 266 |
|
|
2018
Q4 | $200K | Hold |
4,860
| – | – | 0.01% | 243 |
|
|
2018
Q3 | $185K | Buy |
4,860
+200
| +4% | +$7.61K | 0.01% | 252 |
|
|
2018
Q2 | $211K | Buy |
4,660
+100
| +2% | +$4.53K | 0.01% | 249 |
|
|
2018
Q1 | $220K | Buy |
+4,560
| New | +$220K | 0.01% | 248 |
|